ArticleJAMA network open2021

Use of Tumor Necrosis Factor Inhibitors During the COVID-19 Pandemic-Evidence in Favor of Monotherapy.

Licio A VellosoPubMed ↗Publisher ↗

No numbers read from the abstract.